US Stock MarketDetailed Quotes

Cardio Diagnostics (CDIO)

Watchlist
  • 1.810
  • +0.050+2.84%
Close Jan 16 16:00 ET
  • 1.792
  • -0.018-0.98%
Post 17:32 ET
3.31MMarket Cap-0.58P/E (TTM)

Cardio Diagnostics (CDIO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
-56.61%2.86K
-5.02%7.48K
-94.10%940
104.45%34.89K
-15.03%4.51K
-34.40%6.58K
356.23%7.87K
15.93K
1,696.32%17.07K
458.95%5.31K
Operating revenue
-56.61%2.86K
-5.02%7.48K
-94.10%940
104.45%34.89K
-15.03%4.51K
-34.40%6.58K
356.23%7.87K
--15.93K
1,696.32%17.07K
458.95%5.31K
Cost of revenue
Gross profit
Operating expense
21.12%1.71M
30.68%1.69M
-60.91%1.63M
15.72%8.4M
-1.71%1.52M
-2.66%1.42M
-49.50%1.29M
145.08%4.17M
59.57%7.26M
-34.96%1.55M
Selling and administrative expenses
8.13%1.52M
30.68%1.69M
-61.91%1.58M
17.71%8.35M
-1.64%1.51M
-0.37%1.41M
-49.15%1.29M
158.01%4.16M
57.92%7.1M
-34.51%1.54M
-Selling and marketing expense
270.16%192.7K
----
21.56%41.82K
15.10%182.45K
-11.74%38.21K
52.81%52.06K
82.80%57.78K
-30.57%34.4K
71.00%158.51K
59.58%43.29K
-General and administrative expense
-1.95%1.33M
----
-62.61%1.54M
17.77%8.17M
-1.35%1.47M
-1.69%1.35M
-51.30%1.22M
164.00%4.12M
57.64%6.94M
-35.61%1.49M
Research and development costs
3,502.99%189.05K
----
-79.70%2.2K
-79.94%29.13K
-23.14%5.76K
-86.44%5.25K
-40.89%7.28K
-87.49%10.84K
258.93%145.18K
-75.90%7.49K
Depreciation amortization depletion
17.76%5.66K
----
848.01%45.44K
2.90%19.74K
11.39%5.35K
0.00%4.8K
0.02%4.79K
0.17%4.79K
19.89%19.18K
20.05%4.8K
-Depreciation and amortization
17.76%5.66K
----
848.01%45.44K
2.90%19.74K
11.39%5.35K
0.00%4.8K
0.02%4.79K
0.17%4.79K
19.89%19.18K
20.05%4.8K
Operating profit
-21.48%-1.71M
-30.90%-1.68M
60.79%-1.63M
-15.51%-8.37M
1.66%-1.52M
2.44%-1.41M
49.77%-1.28M
-144.14%-4.16M
-59.23%-7.24M
35.16%-1.54M
Net non-operating interest income expense
18.34%-2.94K
18.70%-4.5K
18.64%-4.5K
99.74%-17.58K
96.97%-2.91K
99.37%-3.6K
99.47%-5.54K
99.89%-5.54K
-6.73M
-95.8K
Non-operating interest income
-32.50%189
-32.62%190
-33.45%187
-0.37%1.06K
-26.58%221
-1.06%280
7.22%282
27.15%281
--1.07K
--301
Non-operating interest expense
-19.36%3.13K
-19.37%4.69K
-19.36%4.69K
-99.72%18.64K
-96.75%3.13K
-99.32%3.88K
-99.45%5.82K
-99.88%5.82K
--6.74M
--96.1K
Other net income (expense)
5,075.89%5.6M
248.87K
Gain on sale of security
----
----
----
----
----
----
----
----
--5.41M
---195.83K
Special income (charges)
----
----
----
--0
--0
--0
--0
----
271.81%193.35K
--444.7K
-Less:Other special charges
----
----
----
----
----
----
----
----
---193.35K
---444.7K
Income before tax
-21.38%-1.71M
-30.68%-1.68M
60.73%-1.64M
-0.08%-8.38M
-9.39%-1.52M
26.90%-1.41M
67.98%-1.29M
-303.21%-4.16M
-79.72%-8.38M
41.59%-1.39M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-21.38%-1.71M
-30.68%-1.68M
60.73%-1.64M
-0.08%-8.38M
-9.39%-1.52M
26.90%-1.41M
67.98%-1.29M
-303.21%-4.16M
-79.72%-8.38M
41.59%-1.39M
Net income continuous Operations
-21.38%-1.71M
-30.68%-1.68M
60.73%-1.64M
-0.08%-8.38M
-9.39%-1.52M
26.90%-1.41M
67.98%-1.29M
-303.21%-4.16M
-79.72%-8.38M
41.59%-1.39M
Minority interest income
Net income attributable to the parent company
-21.38%-1.71M
-30.68%-1.68M
60.73%-1.64M
-0.08%-8.38M
-9.39%-1.52M
26.90%-1.41M
67.98%-1.29M
-303.21%-4.16M
-79.72%-8.38M
41.59%-1.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-21.38%-1.71M
-30.68%-1.68M
60.73%-1.64M
-0.08%-8.38M
-9.39%-1.52M
26.90%-1.41M
67.98%-1.29M
-303.21%-4.16M
-79.72%-8.38M
41.59%-1.39M
Basic earnings per share
-1,599.41%-0.98
43.27%-0.97
83.64%-0.97
53.03%-9.3
-0.9921
98.80%-0.0577
85.38%-1.71
-79.70%-5.93
56.29%-19.8
0
Diluted earnings per share
-1,599.41%-0.98
43.27%-0.97
83.64%-0.97
53.03%-9.3
-0.9921
98.80%-0.0577
85.38%-1.71
-79.70%-5.93
56.29%-19.8
0
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue -56.61%2.86K-5.02%7.48K-94.10%940104.45%34.89K-15.03%4.51K-34.40%6.58K356.23%7.87K15.93K1,696.32%17.07K458.95%5.31K
Operating revenue -56.61%2.86K-5.02%7.48K-94.10%940104.45%34.89K-15.03%4.51K-34.40%6.58K356.23%7.87K--15.93K1,696.32%17.07K458.95%5.31K
Cost of revenue
Gross profit
Operating expense 21.12%1.71M30.68%1.69M-60.91%1.63M15.72%8.4M-1.71%1.52M-2.66%1.42M-49.50%1.29M145.08%4.17M59.57%7.26M-34.96%1.55M
Selling and administrative expenses 8.13%1.52M30.68%1.69M-61.91%1.58M17.71%8.35M-1.64%1.51M-0.37%1.41M-49.15%1.29M158.01%4.16M57.92%7.1M-34.51%1.54M
-Selling and marketing expense 270.16%192.7K----21.56%41.82K15.10%182.45K-11.74%38.21K52.81%52.06K82.80%57.78K-30.57%34.4K71.00%158.51K59.58%43.29K
-General and administrative expense -1.95%1.33M-----62.61%1.54M17.77%8.17M-1.35%1.47M-1.69%1.35M-51.30%1.22M164.00%4.12M57.64%6.94M-35.61%1.49M
Research and development costs 3,502.99%189.05K-----79.70%2.2K-79.94%29.13K-23.14%5.76K-86.44%5.25K-40.89%7.28K-87.49%10.84K258.93%145.18K-75.90%7.49K
Depreciation amortization depletion 17.76%5.66K----848.01%45.44K2.90%19.74K11.39%5.35K0.00%4.8K0.02%4.79K0.17%4.79K19.89%19.18K20.05%4.8K
-Depreciation and amortization 17.76%5.66K----848.01%45.44K2.90%19.74K11.39%5.35K0.00%4.8K0.02%4.79K0.17%4.79K19.89%19.18K20.05%4.8K
Operating profit -21.48%-1.71M-30.90%-1.68M60.79%-1.63M-15.51%-8.37M1.66%-1.52M2.44%-1.41M49.77%-1.28M-144.14%-4.16M-59.23%-7.24M35.16%-1.54M
Net non-operating interest income expense 18.34%-2.94K18.70%-4.5K18.64%-4.5K99.74%-17.58K96.97%-2.91K99.37%-3.6K99.47%-5.54K99.89%-5.54K-6.73M-95.8K
Non-operating interest income -32.50%189-32.62%190-33.45%187-0.37%1.06K-26.58%221-1.06%2807.22%28227.15%281--1.07K--301
Non-operating interest expense -19.36%3.13K-19.37%4.69K-19.36%4.69K-99.72%18.64K-96.75%3.13K-99.32%3.88K-99.45%5.82K-99.88%5.82K--6.74M--96.1K
Other net income (expense) 5,075.89%5.6M248.87K
Gain on sale of security ----------------------------------5.41M---195.83K
Special income (charges) --------------0--0--0--0----271.81%193.35K--444.7K
-Less:Other special charges -----------------------------------193.35K---444.7K
Income before tax -21.38%-1.71M-30.68%-1.68M60.73%-1.64M-0.08%-8.38M-9.39%-1.52M26.90%-1.41M67.98%-1.29M-303.21%-4.16M-79.72%-8.38M41.59%-1.39M
Income tax 0000000000
Net income -21.38%-1.71M-30.68%-1.68M60.73%-1.64M-0.08%-8.38M-9.39%-1.52M26.90%-1.41M67.98%-1.29M-303.21%-4.16M-79.72%-8.38M41.59%-1.39M
Net income continuous Operations -21.38%-1.71M-30.68%-1.68M60.73%-1.64M-0.08%-8.38M-9.39%-1.52M26.90%-1.41M67.98%-1.29M-303.21%-4.16M-79.72%-8.38M41.59%-1.39M
Minority interest income
Net income attributable to the parent company -21.38%-1.71M-30.68%-1.68M60.73%-1.64M-0.08%-8.38M-9.39%-1.52M26.90%-1.41M67.98%-1.29M-303.21%-4.16M-79.72%-8.38M41.59%-1.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -21.38%-1.71M-30.68%-1.68M60.73%-1.64M-0.08%-8.38M-9.39%-1.52M26.90%-1.41M67.98%-1.29M-303.21%-4.16M-79.72%-8.38M41.59%-1.39M
Basic earnings per share -1,599.41%-0.9843.27%-0.9783.64%-0.9753.03%-9.3-0.992198.80%-0.057785.38%-1.71-79.70%-5.9356.29%-19.80
Diluted earnings per share -1,599.41%-0.9843.27%-0.9783.64%-0.9753.03%-9.3-0.992198.80%-0.057785.38%-1.71-79.70%-5.9356.29%-19.80
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More